• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Serum Institute's Adar Poonawalla urges US to lift raw material export ban to ramp up vaccine production
SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by AstraZeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries.
Source: The Economic Times Healthcare and Biotech News - April 16, 2021 Category: Pharmaceuticals Source Type: news

Exclusive: Hackers Break Into ‘Biochemical Systems’ At Oxford University Lab Studying Covid-19
Oxford ’s Division of Structural Biology is hacked by a crew that has allegedly sold data to governments. They acquired access to machines preparing biochemical samples.
Source: Forbes.com Healthcare News - February 25, 2021 Category: Pharmaceuticals Authors: Thomas Brewster, Forbes Staff Tags: Cybersecurity /cybersecurity Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick News Breaking breaking-news Coronavirus technology Source Type: news

Oxford/AstraZeneca jab effective against UK Covid variant, finds study
Oxford University scientists who developed the ChAdOx1-nCoV19 vaccine have found that it remains effective against at least one of the new variants of the disease, called the B.1.1.7 'Kent' coronavirus strain after the south-east England region where it was first discovered late last year.
Source: The Economic Times Healthcare and Biotech News - February 7, 2021 Category: Pharmaceuticals Source Type: news

South Africa's regulatory body approves Serum Institute of India's coronavirus vaccine
Health Minister Zweli Mkhize announced on Friday that the South African Health Products Regulatory Authority (SAHPRA) has granted approval to the SII, which is producing the vaccine in collaboration with the University of Oxford and AstraZeneca, to supply the drug to the country.
Source: The Economic Times Healthcare and Biotech News - January 23, 2021 Category: Pharmaceuticals Source Type: news

India to start coronavirus vaccine exports as soon as Wednesday, starting with Bhutan
Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will also be despatched to Bangladesh on Thursday, said officials briefed on the plans.
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

After Covishield and Covaxin, the other vaccine candidates in India
As India prepares for one of the world's biggest vaccination campaigns, the DCGI has authorised the use of two coronavirus vaccines for emergency use- one developed by Oxford University-AstraZeneca 'Covidshield' and the other by Bharat Biotech 'Covaxin'.
Source: The Economic Times Healthcare and Biotech News - January 4, 2021 Category: Pharmaceuticals Source Type: news

Here ’s What You Need To Know About AstraZeneca’s Covid-19 Vaccine
AstraZeneca, with partner Oxford University, released preliminary data for its phase 3 Covid-19 Monday showing that the vaccine may be up to 90% effective.
Source: Forbes.com Healthcare News - November 23, 2020 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Coronavirus Decision Maker Content decisionmaker technology alexknappblog Source Type: news

Coronavirus/vaccines: safety in numbers
AstraZeneca and Oxford university jab should make big contribution to immunisation effort
Source: FT.com - Drugs and Healthcare - November 23, 2020 Category: Pharmaceuticals Source Type: news

How the vaccine developed by Oxford University stacks up against Pfizer and Moderna
AstraZeneca said November 23 that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is easier to distribute than some of its rivals.
Source: The Economic Times Healthcare and Biotech News - November 23, 2020 Category: Pharmaceuticals Source Type: news

Oxford University coronavirus vaccine could be rolled out within six months: Report
The vaccine candidate under trial by University of Oxford scientists in collaboration with pharmaceutical giant AstraZeneca is the furthest in the process of trials and, according to a report in ‘The Times', it could be given the required clearances by Christmas in December.
Source: The Economic Times Healthcare and Biotech News - October 2, 2020 Category: Pharmaceuticals Source Type: news

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse event
AstraZeneca has paused all clinical trials of the Covid-19 vaccine it is developing with Oxford university after a participant in the UK section of the study suffered a suspected serious adverse reaction. Shares in the drugmaker slid after study of coronavirus jab put on hold to ‘review safety data.’
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 9, 2020 Category: Pharmaceuticals Authors: Hannah Kuchler in New York and Sarah Neville in London Source Type: news

AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
The Phase 3 clinical trial will evaluate AstraZeneca ’s AZD1222 Covid-19 coronavirus vaccine candidate, which was originally developed at Oxford University.
Source: Forbes.com Healthcare News - September 1, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick Coronavirus pharma Source Type: news

Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials Show
The vaccine is still in early-stage clinical trials, and it is yet to be seen whether it can protect people against the virus.
Source: Forbes.com Healthcare News - July 20, 2020 Category: Pharmaceuticals Authors: Isabel Togoh, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news

Oxford coronavirus vaccine prompts immune response in early test
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Receives Positive CHMP Opinion for Janssen ’s Investigational Preventive Ebola Vaccine Regimen
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order to trigger an immun...
Source: Johnson and Johnson - May 29, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news